Clinical Trial Update: AK112 and Cadonilimab Combined With Chemotherapy for 1L Treatment of Metastatic Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update indicates that AK112 plus Cadonilimab in combination with chemotherapy is being evaluated as first-line treatment for metastatic panc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• AK112
• Cadonilimab

Snippet

Sponsor: Akeso | Conditions: Metastatic Pancreatic Ductal Adenocarcinoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING